Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Pain, Postoperative 4Chronic Pain 3Agnosia 3Stomach Neoplasms 1Rectal Neoplasms 1Pain 1Neuroma 1Myofibroma 1Multiple Pulmonary Nodules 1Maxillofacial Tumors 1Leiomyoma 1Ileus 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Cancer Surgery 1Abdominal Cancer 1Abdomen, Acute 1

Interventions

telapristone acetate 18ulipristal acetate 17Uterine Myomectomy 13vilaprisan 12Leuprolide 11relugolix 9estradiol, norethindrone drug combination 9asoprisnil 9elagolix 7Uterine Artery Embolization 7Mifepristone 7Estradiol 7Bupivacaine 7ulipristal 6Tranexamic Acid 6Saline Solution 5Norethindrone Acetate 5linzagolix 4epigallocatechin gallate 4Sodium Chloride 4Letrozole 4Hysterectomy 4Vitamin B 6 3Sugars 3Misoprostol 3Lidocaine 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Leiomyoma × Anesthetics, Local × Clear all
NCT02293447 2016-05-12

Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization

University Health Network, Toronto

Phase 4 Completed
60 enrolled

Leiomyoma, Pain, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡